Page last updated: 2024-10-24

candesartan and Hematoma

candesartan has been researched along with Hematoma in 1 studies

candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.

Hematoma: A collection of blood outside the BLOOD VESSELS. Hematoma can be localized in an organ, space, or tissue.

Research Excerpts

ExcerptRelevanceReference
" We assessed the effects of treatment with candesartan in acute ICH and according to different types of hematoma."9.30Effects of Candesartan in the Acute Phase of Intracerebral Hemorrhage. ( Anderson, C; Bath, PM; Berge, E; Berge, TE; Delcourt, C; Guo, R; Jusufovic, M; Karlson, BW; Sandset, EC; You, S, 2019)
" We assessed the effects of treatment with candesartan in acute ICH and according to different types of hematoma."5.30Effects of Candesartan in the Acute Phase of Intracerebral Hemorrhage. ( Anderson, C; Bath, PM; Berge, E; Berge, TE; Delcourt, C; Guo, R; Jusufovic, M; Karlson, BW; Sandset, EC; You, S, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jusufovic, M1
Berge, TE1
Guo, R1
You, S1
Delcourt, C1
Anderson, C1
Bath, PM1
Karlson, BW1
Berge, E1
Sandset, EC1

Trials

1 trial available for candesartan and Hematoma

ArticleYear
Effects of Candesartan in the Acute Phase of Intracerebral Hemorrhage.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2019, Volume: 28, Issue:8

    Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimida

2019